首页> 外国专利> AGT GENE POLYMORPHISMS MARKER FOR DIAGNOSING ASPIRIN INTOLERANT ASTHMA WITH MODIFIED RESPONSE TO MONTELUKAST TREATMENT

AGT GENE POLYMORPHISMS MARKER FOR DIAGNOSING ASPIRIN INTOLERANT ASTHMA WITH MODIFIED RESPONSE TO MONTELUKAST TREATMENT

机译:AGT基因多态性标记物,用于诊断阿司匹林耐受不良的哮喘,对孟鲁司特治疗的反应有所改善

摘要

PURPOSE: An AGT gene polymorphism marker for diagnosing AIA(aspirin intolerant asthma) is provided to prevent and treat asthma as a pharmacological marker. CONSTITUTION: An AGT(anginotensinogen) gene polymorphism marker for diagnosing AIA(aspirin intolerant asthma) responses to a therapeutic agent for asthma. The marker contains SNP from a polynucleotide with a DNA sequence of sequence number 1. A SNP has 546th base(T or C), 6991th(C or G), and 7066th(C or T). A method for detecting AGT gene polymorphism marker comprises: a step of isolating genome DNA from a test sample; and a step of detecting polynucleotide in the genome DNA.
机译:目的:提供一种用于诊断AIA(阿司匹林耐受性哮喘)的AGT基因多态性标志物,作为预防和治疗哮喘的药理标志物。构成:AGT(血管紧张素原)基因多态性标志物,用于诊断AIA(阿司匹林耐受性哮喘)对哮喘治疗药的反应。标记包含来自具有序列号1的DNA序列的多核苷酸的SNP。SNP具有第546个碱基(T或C),6991个(C或G)和7066个(C或T)。一种检测AGT基因多态性标记的方法,包括:从测试样品中分离基因组DNA的步骤;检测基因组DNA中的多核苷酸的步骤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号